Aaron Kucinski

817 total citations
23 papers, 612 citations indexed

About

Aaron Kucinski is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Aaron Kucinski has authored 23 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Aaron Kucinski's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Balance, Gait, and Falls Prevention (7 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). Aaron Kucinski is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Balance, Gait, and Falls Prevention (7 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). Aaron Kucinski collaborates with scholars based in United States, Denmark and Poland. Aaron Kucinski's co-authors include Martin Sarter, Roger L. Albin, Cindy Lustig, Michal K. Stachowiak, Merouane Bencherif, Scott R. Wersinger, Ewa K. Stachowiak, Kristen G. Jordan, Patrick M. Lippiello and Giovanna Paolone and has published in prestigious journals such as Journal of Neuroscience, Biochemical Pharmacology and Psychopharmacology.

In The Last Decade

Aaron Kucinski

23 papers receiving 601 citations

Peers

Aaron Kucinski
Deranda B. Lester United States
N. Dürmüller United Kingdom
M Kungel Germany
Ann M. Hemmerle United States
Xingjie Ping United States
Tamara Markovic United States
John I. Broussard United States
Deranda B. Lester United States
Aaron Kucinski
Citations per year, relative to Aaron Kucinski Aaron Kucinski (= 1×) peers Deranda B. Lester

Countries citing papers authored by Aaron Kucinski

Since Specialization
Citations

This map shows the geographic impact of Aaron Kucinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Kucinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Kucinski more than expected).

Fields of papers citing papers by Aaron Kucinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Kucinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Kucinski. The network helps show where Aaron Kucinski may publish in the future.

Co-authorship network of co-authors of Aaron Kucinski

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Kucinski. A scholar is included among the top collaborators of Aaron Kucinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Kucinski. Aaron Kucinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kucinski, Aaron, et al.. (2022). Basal Forebrain Chemogenetic Inhibition Converts the Attentional Control Mode of Goal-Trackers to That of Sign-Trackers. eNeuro. 9(6). ENEURO.0418–22.2022. 4 indexed citations
2.
Kucinski, Aaron & Martin Sarter. (2021). Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071. Psychopharmacology. 238(7). 1953–1964. 7 indexed citations
3.
Kucinski, Aaron, et al.. (2020). Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons. Journal of Neuroscience. 40(31). 6049–6067. 17 indexed citations
4.
Cherian, Ajeesh Koshy, et al.. (2019). Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson’s disease. Psychopharmacology. 236(6). 1701–1715. 7 indexed citations
5.
Cherian, Ajeesh Koshy, Natalie C. Tronson, Vinay Parikh, et al.. (2019). Repetitive mild concussion in subjects with a vulnerable cholinergic system: Lasting cholinergic-attentional impairments in CHT+/− mice.. Behavioral Neuroscience. 133(4). 448–459. 6 indexed citations
6.
Kucinski, Aaron, et al.. (2019). Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071. Psychopharmacology. 237(1). 137–153. 22 indexed citations
7.
Kucinski, Aaron, Youngsoo Kim, & Martin Sarter. (2019). Basal forebrain chemogenetic inhibition disrupts the superior complex movement control of goal-tracking rats.. Behavioral Neuroscience. 133(1). 121–134. 12 indexed citations
8.
Kucinski, Aaron, Cindy Lustig, & Martin Sarter. (2018). Addiction vulnerability trait impacts complex movement control: Evidence from sign-trackers. Behavioural Brain Research. 350. 139–148. 12 indexed citations
9.
Cherian, Ajeesh Koshy, Aaron Kucinski, Kyle K. Pitchers, et al.. (2017). Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases. Journal of Neuroscience. 37(11). 2947–2959. 27 indexed citations
10.
Kucinski, Aaron & Martin Sarter. (2015). Modeling Parkinson’s disease falls associated with brainstem cholinergic systems decline.. Behavioral Neuroscience. 129(2). 96–104. 33 indexed citations
11.
Kucinski, Aaron, Roger L. Albin, Cindy Lustig, & Martin Sarter. (2015). Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss. Behavioural Brain Research. 282. 155–164. 29 indexed citations
12.
Sarter, Martin, Roger L. Albin, Aaron Kucinski, & Cindy Lustig. (2014). Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Experimental Neurology. 257. 120–129. 90 indexed citations
15.
Bencherif, Merouane, Michal K. Stachowiak, Aaron Kucinski, & Patrick M. Lippiello. (2012). Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia. Medical Hypotheses. 78(5). 594–600. 31 indexed citations
16.
Stachowiak, Michal K., Aaron Kucinski, Sridhar Narla, et al.. (2012). Schizophrenia: A neurodevelopmental disorder — Integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophrenia Research. 143(2-3). 367–376. 37 indexed citations
18.
Kucinski, Aaron, Michal K. Stachowiak, Scott R. Wersinger, Patrick M. Lippiello, & Merouane Bencherif. (2011). Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia. Current Pharmaceutical Biotechnology. 12(3). 437–448. 20 indexed citations
19.
Hauser, Terry A., Aaron Kucinski, Kristen G. Jordan, et al.. (2009). TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochemical Pharmacology. 78(7). 803–812. 114 indexed citations
20.
Klejbor, Ilona, Aaron Kucinski, Scott R. Wersinger, et al.. (2009). Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis. Schizophrenia Research. 113(2-3). 308–321. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026